Modulation of Endothelial Cell Survival by an Inhibitor of Angiogenesis Thrombospondin-1: a Dynamic Balance

被引:0
作者
O.V. Volpert
机构
[1] Northwestern University Medical School,Department of Urology and R.H. Lurie Comprehensive Cancer Center
来源
Cancer and Metastasis Reviews | 2000年 / 19卷
关键词
angiogenesis; endothelial cell survival; apoptosis; thrombospondin-1;
D O I
暂无
中图分类号
学科分类号
摘要
Angiogenesis is a process of capillary formation from pre-existing blood vessels. It is tightly controlled by the balance between positive and negative environmental signals – inducers and inhibitors of angiogenesis in such a way that predominance of inducers results in angiogenesis and predominance of inhibitors – in vascular quiescence. Here we discuss the ability of the angiogenic stimuli to promote survival and the pathways they may utilize. We also summarize information available on the signaling events elicited in the endothelial cells by a naturally occurring inhibitor of angiogenesis Thrombospondin-1 (TSP-1), that result in the endothelial cell apoptosis and inhibition of angiogenesis in vivo. This ability to cause programmed cell death in vascular endothelium is not unique to TSP-1. A substantial number of known angiogenesis inhibitors can also trigger apoptosis in the activated endothelial cells. This fact argues for the possibility of apoptosis to be a common denominator for a major fraction of anti-angiogenic molecules. If this is the case, it is equally possible that the ratio between environmental factors that control angiogenesis is interpreted within individual endothelial cell as a balance between pro-apoptotic and survival signals. Thus the relative strength of the death and survival signal or signals determines the fate of endothelial cell and therefore the fate of remodeling vessel.
引用
收藏
页码:87 / 92
页数:5
相关论文
共 231 条
[1]  
Folkman J(1998)Is tissue mass regulated by vascular endothelial cells? Prostate as the first evidence Endocrinology 139 441-442
[2]  
Hanahan D(1996)Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 86 353-364
[3]  
Folkman J(1996)Blood vessel formation: what is its molecular basis? Cell 87 1153-1155
[4]  
Folkman J(1998)Establishing a link between oncogenes and tumor angiogenesis Molec Medi 4 286-295
[5]  
D'Amore PA(1997)Sequential development of an angiogenic phenotype by human fibroblasts progressing to tumorigenicity Oncogene 14 1495-1502
[6]  
Kerbel RS(1997)The von Hippel-Lindau gene product inhibits vascular permeability factor/vascular endothelial growth factor expression in renal cell carcinoma by blocking protein kinase C pathways J Biol Chem 272 27 509-27 512
[7]  
Viloria-Petit A(1994)Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1 Science 265 1582-1584
[8]  
Okada F(1999)Angiogenesis: how a tumor adapts to hypoxia Biochem Biophys Res Commun 266 718-722
[9]  
Rak J(1998)p53 inhibits hypoxia-inducible factor-stimulated transcription J Biol Chem 273 11 995-11 998
[10]  
Volpert OV(1999)The tumor suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis Nature 399 271-275